Njord Medtech® is pleased to have Gunborg Polson as the newly appointed Chief Financial Officer.
Gunborg has worked in a consultancy capacity during the last year and will now join the team in a formal position.
Gunborg has solid financial acumen and international growth build-up experience as Senior Advisor, vice president, and CFO to Cochlear, Group Controller at Nobel Biocare, and CFO at spin-out company with international build-up and divestment to Cochlear Solutions. Gunborg holds an MBA from Gothenburg University.
“Gunborg's experience building up MedTech companies from zero sales to +500 MSEK/yr sales across international markets with underlying processes and partner network will be highly beneficial for Njord going forward. Happy to have Gunborg onboard and truly look forward to work closely with Gunborg”, commented Jacob Ahrnstein